|
|
Oxygen (O2) transport and hemostasis are central to human adaptation to stress/damage and to disease pathobiology. The interdisciplinary Center for Blood Oxygen Transport & Hemostasis (CBOTH) addresses elementary, difficult questions associated to blood O2 transport and hemostasis from a techniques perspective, with consideration to human biology, physiology and therapeutics. Innovative examine of O2 transport, hemostasis and key interacting biologic methods crosses conventional disciplines; furthermore, efficient therapeutic growth bridges typical levels of pharmaceutical & bioengineering development. CBOTH surmounts this challenge by integrating effort from leading investigators throughout disciplines and engagement across the translational pipeline. Through these interdisciplinary efforts, CBOTH will advance the event of an artificial blood product for use in trauma settings without quick access to donated blood for transfusions, comparable to battlefields or rural areas. CBOTH includes a crew of physicians, biochemists and engineers who are working to answer fundamental, difficult questions related to blood operate in the setting of critical sickness. In partnership with the UMB BioPark, CBOTH hosts startups, creating novel technologies that emerge from Center laboratories. KaloCyte is the primary such startup at CBOTH, creating the ErythroMer synthetic crimson blood cell design into a pragmatic therapeutic.
Here is my website :: BloodVitals health |
|
發表於